SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference
July 29 2022 - 7:00AM
SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven
medicine, announced today Chief Financial Officer, Ross Muken, will
attend and be a panelist at the Canaccord Genuity 42nd Annual
Growth Conference on Thursday, August 11, 2022 at the
InterContinental Hotel in Boston, MA, United States.
Ross will join other industry leaders for the panel “Leveraging
Omics-Based Data and Analytics to Advance Precision Health to the
Next Level,” starting at 9:30 a.m. EST.
A live webcast and replay of the session will be available on
the investor relations section of the SOPHiA GENETICS website at
https://ir.sophiagenetics.com.
About SOPHiA GENETICSSOPHiA GENETICS (Nasdaq:
SOPH) is a healthcare technology company dedicated to establishing
the practice of data-driven medicine as the standard of care and
for life sciences research. It is the creator of the SOPHiA DDM™
Platform, a cloud-native platform capable of analyzing data and
generating insights from complex multimodal data sets and different
diagnostic modalities. The SOPHiA DDM™ Platform and related
solutions, products and services are currently used by more than
790 hospital, laboratory, and biopharma institutions globally. For
more information, visit SOPHiAGENETICS.COM, or connect on Twitter,
LinkedIn and Instagram. Where others see data, we see
answers.
Investor Contact:Jennifer PottageHead of
Investor RelationsJpottage@sophiagenetics.com
Media Contact:Don GranesePublic
RelationsDgranese@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From May 2024 to Jun 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jun 2023 to Jun 2024